Fig. 6From: A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validationThe HPLC–MS of CKI and standard substances. The red and the blue represents CKI and standard substances respectively. 10 compounds were identified by HPLC–MS, including oxysophocarpine, matrine, sophocarpine, sophoridine, oxynamatrine, N-methylcytisine, sophoranol, liriodendrin, trifolirhizin and macrozaminBack to article page